Effect of atorvastatin on glycaemia progression in patients with diabetes: an analysis from the Collaborative Atorvastatin in Diabetes Trial (CARDS)

Effect of atorvastatin on glycaemia progression in patients with diabetes: an analysis from the Collaborative Atorvastatin in Diabetes Trial (CARDS)

Bibliographic Details
Main Authors:	Livingstone, Shona J., Looker, Helen C., Akbar, Tahira, Betteridge, D. John, Durrington, Paul N., Hitman, Graham A., Neil, H. Andrew W., Fuller, John H., Colhoun, Helen M.
Format:	Online
Language:	English
Published:	Springer Berlin Heidelberg 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705133/

Similar Items

Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial
by: Soedamah-Muthu, Sabita S., et al.
Published: (2015)

Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a) [S]
by: Deshmukh, Harshal A., et al.
Published: (2012)

Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients With Type 2 Diabetes: An Analysis From the CARDS Trial
by: Colhoun, Helen M., et al.
Published: (2011)

Effects of Atorvastatin on Nitrate Tolerance in Diabetic Rats
by: Imenshahidi, Mohsen, et al.
Published: (2010)

Rosuvastatin and Atorvastatin: Comparative Effects on Glucose Metabolism in Non-Diabetic Patients with Dyslipidaemia
by: Abbas, Ahmed, et al.
Published: (2012)

Atorvastatin-induced acute pancreatitis
by: Deshpande, Prasanna R., et al.
Published: (2011)

Atorvastatin solid dispersion for bioavailability enhancement
by: Shamsuddin,, et al.
Published: (2016)

Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients
by: Barakat, Lolwa, et al.
Published: (2013)

Renoprotective effects of atorvastatin compared with pravastatin on progression of early diabetic nephropathy
by: Takazakura, Akiko, et al.
Published: (2015)

The Effects of Atorvastatin on Arterial Stiffness in Male Patients with Type 2 Diabetes
by: Davenport, Colin, et al.
Published: (2015)

The role of atorvastatin on the restenosis process post-PTA in a diabetic rabbit model
by: Zhou, Xiaojun, et al.
Published: (2016)

Formulation and Evaluation of Mouth Disintegrating Tablets of Atenolol and Atorvastatin
by: Sarfraz, R. M., et al.
Published: (2015)

Atorvastatin and sildenafil lower blood pressure and improve endothelial dysfunction, but only atorvastatin increases vascular stores of nitric oxide in hypertension☆
by: Guimarães, Danielle A., et al.
Published: (2013)

Assessment of Atorvastatin Effect on Body Weight and Blood Glucose Levels Among Diabetic and Non-Diabetic Patients
by: Al-Bayyari Nahla, et al.
Published: (2017-09-01)

Efficacy of alternate-day versus everyday dosing of atorvastatin
by: Pramanik, Sushobhan, et al.
Published: (2012)

Atorvastatin prevents Plasmodium falciparum cytoadherence and endothelial damage
by: Taoufiq, Zacharie, et al.
Published: (2011)

Pharmacokinetic interaction of garlic and atorvastatin in dyslipidemic rats
by: Reddy, G. Dilip, et al.
Published: (2012)

In vitro dissolution study of atorvastatin binary solid dispersion
by: Jahan, Rahat, et al.
Published: (2013)

Effects of long-term atorvastatin treatment on cardiac aging
by: HAN, LEI, et al.
Published: (2013)

Combination therapy of atorvastatin and probucol on ischemic stroke in clinic
by: Yan, Tao, et al.
Published: (2012)

The Comparative Effects of Atorvastatin and Quince Leaf Extract on Atherosclerosis
by: Khademi, Farzaneh, et al.
Published: (2013)

Synergistic effects of colchicine combined with atorvastatin in rats with hyperlipidemia
by: Huang, Congwu, et al.
Published: (2014)

Atorvastatin and simvastatin as analgesic agents in experimental models
by: Dwajani, S., et al.
Published: (2012)

Acute hepatic injury with atorvastatin: An unusual occurrence
by: Vishwakarma, Pinki, et al.
Published: (2014)

EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES
by: A. N. Meshkov
Published: (2010-01-01)

EFFICIENCY AND SAFETY ASSESSMENT OF GENERIC ATORVASTATINE IN PATIENTS WITH HYPERLIPIDEMIA
by: J. E. Semyonova, et al.
Published: (2005-01-01)

STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN
by: N. G. Gogolashvili
Published: (2014-01-01)

Acute-onset rhabdomyolysis secondary to sitagliptin and atorvastatin interaction
by: Khan, Muhammad Waqas, et al.
Published: (2016)

Safety of atorvastatin in Asian patients within clinical trials
by: Chan, Juliana C. N., et al.
Published: (2016)

Optimized zein nanospheres for improved oral bioavailability of atorvastatin
by: Hashem, Fahima M, et al.
Published: (2015)

Dose-dependent effects of atorvastatin on myocardial infarction
by: Barbarash, Olga, et al.
Published: (2015)

Pemphigus erythematosus relapse associated with atorvastatin intake
by: Lo Schiavo, Ada, et al.
Published: (2014)

An improved kilogram-scale preparation of atorvastatin calcium
by: Novozhilov, Yuri V, et al.
Published: (2015)

Systematic review of atorvastatin for the treatment of Alzheimer's disease★
by: Sun, Yuan, et al.
Published: (2012)

Atorvastatin May Attenuate Recurrence of Chronic Subdural Hematoma
by: Liu, Hua, et al.
Published: (2016)

Atorvastatin treatment modulates the interaction between leptin and adiponectin, and the clinical parameters in patients with type II diabetes
by: AL-AZZAM, SAYER I., et al.
Published: (2013)

Atorvastatin activates heme oxygenase-1 at the stress response elements
by: Kwok, Simon CM, et al.
Published: (2012)

Cost-effectiveness analysis of low density lipoprotein cholesterol-lowering therapy in hypertensive patients with type 2 diabetes in Korea: single-pill regimen (amlodipine/atorvastatin) versus double-pill regimen (amlodipine+atorvastatin)
by: Park, Ji-Hyun, et al.
Published: (2015)

Atorvastatin in the treatment of Lithium-induced nephrogenic diabetes insipidus: the protocol of a randomized controlled trial
by: Jocelyn Fotso Soh, et al.
Published: (2018-07-01)

Contemporary Risk of Hip Fracture in Type 1 and Type 2 Diabetes: A National Registry Study From Scotland†
by: Hothersall, Eleanor J, et al.
Published: (2014)